Your browser doesn't support javascript.
loading
Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab: A Secondary Analysis of the HERA Trial.
Loi, Sherene; Dafni, Urania; Karlis, Dimitris; Polydoropoulou, Varvara; Young, Brandon M; Willis, Scooter; Long, Bradley; de Azambuja, Evandro; Sotiriou, Christos; Viale, Giuseppe; Rüschoff, Josef; Piccart, Martine J; Dowsett, Mitch; Michiels, Stefan; Leyland-Jones, Brian.
Afiliação
  • Loi S; Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
  • Dafni U; Frontier Science Foundation- Hellas, Athens, Greece3University of Athens, Athens, Greece.
  • Karlis D; Frontier Science Foundation- Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece.
  • Polydoropoulou V; Frontier Science Foundation- Hellas, Athens, Greece.
  • Young BM; Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota.
  • Willis S; Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota.
  • Long B; Department of Pathology, University of Chicago, Chicago, Illinois.
  • de Azambuja E; BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium.
  • Sotiriou C; Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium.
  • Viale G; University of Milan, European Institute of Oncology, Milan, Italy.
  • Rüschoff J; Targos Molecular Pathology GmbH, Kassel, Germany.
  • Piccart MJ; Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium.
  • Dowsett M; Royal Marsden Hospital, London, England.
  • Michiels S; INSERM U1018 CESP, Service de Biostatistique et d'Epidémiologie, Villejuif, France.
  • Leyland-Jones B; Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota.
JAMA Oncol ; 2(8): 1040-7, 2016 Aug 01.
Article em En | MEDLINE | ID: mdl-27100299
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / RNA Mensageiro / Carcinoma / Receptor ErbB-2 / Receptor alfa de Estrogênio / Trastuzumab / Antineoplásicos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: JAMA Oncol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / RNA Mensageiro / Carcinoma / Receptor ErbB-2 / Receptor alfa de Estrogênio / Trastuzumab / Antineoplásicos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: JAMA Oncol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Austrália